| Activity |
|
|
|
Improving Patient Outcomes in Snoring and Sleep Apnea
This CME activity will enable participants to better understand and differentiate between snoring and sleep apnea. Management strategies for both disorders will be discussed as well as the significant morbidities of sleep apnea.
More Info >>
|
|
The Unique Challenges of Managing Depression in Mid-Life Women
View the web archive of a special "Ask the Expert" panel discussion filmed at the World Psychiatric Association's International Congress 2007, in Melbourne, Australia.
More Info >>
|
The Unique Challenges of Managing Depression in Mid-Life Women: White Paper from Proceedings at the WPA International Congress held on November 30, 2007 in Melbourne, Australia
As the baby-boomer generation of women approaches and passes menopause, mid-life depression has become a serious public health issue and the subject of interest of a growing number of epidemiological and clinical studies. Prof. Lorraine Dennerstein and Dr. Claudio Soares examine the evidence for and the nature of relationships between mood symptoms and aging in women, including chronological and reproductive aging, and between mood symptoms and other psychosocial, lifestyle, and health factors.
More Info (PDF)>>
|
Depression During the Menopausal Transition: A Critical Review of Risk Factors and Evidence-Based Treatment Strategies
In this webcast, results of recent community-based studies that delineate the risk for first onset depression and recurrence of depressive illness across the menopausal transition will be reviewed. The extent to which factors such as hot flashes and sleep disturbance modulate risk for depression among women transitioning to menopause will also be discussed. Other presentations will describe the existing data on hormonal and non-hormonal strategies used for the management of menopause-related somatic and psychological symptoms in this population of women.
More Info >>
|
Hormonal Contraception: Controversial Issues
This CME activity will help clarify the current state of clinical knowledge with respect to hormonal contraception through an interactive open forum using case-based learning.
More Info >>
|
|
Diagnosis and Treatment Issues in Adult ADHD
A patient with ADHD requires a multifactorial assessment for an appropriate diagnosis as well as a highly individualized treatment plan that may include a stimulant or nonstimulant compound. Each regimen must be based on a process of initiation, titration, and monitoring of the patient for safety and efficacy. This is of particular concern during the management of adolescents and adults. This CME activity is intended to help overcome existing barriers to effective treatment as a means to improve patient outcomes.
|
Attention Deficit Hyperactivity Disorder and Comorbid Conditions in Adults: Case Studies in Diagnosis and Treatment
ADHD in adults is a relatively recently recognized psychiatric disorder that affects up to 5.0% of the U.S. adult population. The clinical interview remains the basis of the adult ADHD diagnosis. An individualized treatment plan is the hallmark of therapy for adult ADHD, which is complicated by a high rate of comorbid psychiatric conditions requiring evaluation and treatment. Thomas Spencer, MD provides an in-depth opportunity to learn about current and emerging data on the diagnosis, quality of life impact, and management of ADHD and related psychiatric comorbid conditions in adults, with the aim of improving patient outcomes.
More Info >>
|
Impact of ADHD and its Treatment on Substance Abuse
ADHD requires a multifactorial assessment of a patient for appropriate diagnosis as well as a highly individualized treatment plan that may include a stimulant or non-stimulant compound. Each regimen must be based on a process of initiation, titration, and monitoring of the patient for safety and efficacy. We invite you to join Dr. Timothy Wilens in an in-depth CME activity as he discusses emerging data on the impact of ADHD and its treatment on SUD, especially as related to adolescents and adults.
More Info >>
|
Attention Deficit Hyperactivity Disorder and Co-Morbid Conditions in Adolescents and Adults
Two cases will be introduced in this activity through viewing of the video interchange between the patients and their clinical psychiatrist. Following a recap of each case, issues critical to diagnosing and managing adolescent and adult ADHD and their co-morbidities will be presented, leading to an analysis of next steps for each patient.
More Info >>
|
Adolescence and Beyond: A Didactic Approach to ADHD
This CME activity derives from a live activity held June 23, 2007 in New York City, and will help clarify the current state of clinical knowledge in adolescent and adult ADHD.
More Info >>
|
Adolescence and Beyond: A Case-Based and Didactic Approach to ADHD
Using a combination of didactic instruction and case-based learning in a highly interactive forum, this CME activity will help clarify the current state of clinical knowledge in adolescent and adult ADHD.
More Info >>
|
|
Optimizing Treatment Strategies and Outcomes in Patients with Renal Cell Carcinoma (RCC)
Approximately 40,000 new cases of RCC are diagnosed each year in the United States with an estimated 13,000 to 16,000 deaths. RCC is the most common malignancy of the kidney, totaling about 3% of all adult cancers in the United States and 2% of all cancers worldwide. This interactive case- and Web-based, CME-certified activity will provide a critical examination of treatment options for RCC.
More Info >>
|
Targeted Cancer Therapy: From Trial to Clinic
This CME-certified activity is a reproduction of a regional symposium that was held at the Boston Park Plaza Hotel on December 15, 2007 in Boston, MA. It includes an innovative and in-depth view on how integration of targeted and conventional therapies for treating cancer is improving patient outcomes.
More Info >>
|
Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
More Info >> |
New Frontiers in Targeted Therapy for Renal Cell Carcinoma
This activity is designed to educate clinicians on the most common malignancy of the kidney, renal cell carcinoma. Review evolving treatment strategies and best practices with Drs. Escudier, Eisen, and Rini.
More Info >> |
